Results 231 to 240 of about 2,987,261 (338)

Studies on Deoxyribonucleic Acid Polymerase from Ehrlich Ascites Tumor Cells

, 1969
Ranajit Roychoudhury, David P. Bloch
openalex   +1 more source

Further Studies on the Oxidation of Extramitochondrial Reduced Nicotineamide-Adenine Dinucleotide in Landschuetz Ascites Tumor Cells [PDF]

, 1968
Y. Melnik, Leah Bloch-Frankenthal
openalex   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Deciphering Breast Tumor Heterogeneity Through Patient-Derived Organoids and Circulating Tumor Cells. [PDF]

J Pers Med
Policastro B, Nissen N, Alves CL.
europepmc   +1 more source

COMPARISON OF TECHNIQUES FOR OBTAINING SINGLE CELL SUSPENSIONS FROM TUMORS

, 1967
Paula Carney, Richard A. Malmgren
openalex   +1 more source

Growth of human tumor cells in vitro and in vivo [PDF]

, 1964
George E. Moore, Akihiko Koike
openalex   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Enhanced bioluminescence imaging of tumor cells surviving chemotherapy in a murine model of triple-negative breast cancer. [PDF]

NPJ Breast Cancer
Steinbauer S, Cowles JD, Sabbaghi MA, Poppelaars M, Hussain A, Wagesreither M, Laimer-Gruber D, Tovari J, Szakacs G, Csiszar A.   +9 more
europepmc   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Identification of multiple genomic alterations and prediction of neoantigens from circulating tumor cells at the single-cell level. [PDF]

Nat Commun
Gao X, Li X, Xu W, Jiao M, Guo Y, Wang J, Wang W, Feng J, Guo Q, Wu C, Zhang T, Yang Y, Lin D.   +12 more
europepmc   +1 more source